Shell Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$262K Sell
3,570
-4,872
-58% -$324K 0.03% 430
2025
Q2
$439K Sell
8,442
-1,488
-15% -$84.7K 0.02% 519
2025
Q1
$634K Sell
9,930
-480
-5% -$27.9K 0.03% 398
2024
Q4
$498K Sell
10,410
-15
-0.1% -$769 0.02% 494
2024
Q3
$597K Buy
+10,425
New +$598K 0.03% 430
2024
Q1
$552K Buy
10,535
+1,947
+23% +$73K 0.03% 433
2023
Q4
$317K Sell
8,588
-2,568
-23% -$96.7K 0.01% 696
2023
Q3
$426K Sell
11,156
-194
-2% -$7.95K 0.02% 616
2023
Q2
$409K Buy
11,350
+2,367
+26% +$80.8K 0.02% 661
2023
Q1
$343K Sell
8,983
-31
-0.3% -$1.45K 0.01% 725
2022
Q4
$513K Sell
9,014
-1,808
-17% -$92.6K 0.02% 524
2022
Q3
$428K Sell
10,822
-638
-6% -$28.2K 0.02% 644
2022
Q2
$504K Buy
11,460
+3,422
+43% +$148K 0.01% 713
2022
Q1
$321K Sell
8,038
-1,188
-13% -$42.3K 0.01% 1014
2021
Q4
$371K Buy
9,226
+44
+0.5% +$1.64K 0.01% 1024
2021
Q3
$374K Sell
9,182
-390
-4% -$16.3K 0.01% 990
2021
Q2
$435K Buy
9,572
+3,566
+59% +$158K 0.01% 979
2021
Q1
$250K Sell
6,006
-7,140
-54% -$326K 0.01% 1089
2020
Q4
$561K Hold
13,146
0.01% 749
2020
Q3
$345K Hold
13,146
0.01% 846
2020
Q2
$352K Sell
13,146
-145
-1% -$3.27K 0.01% 819
2020
Q1
$239K Sell
13,291
-202
-1% -$3.83K 0.01% 952
2019
Q4
$239K Sell
13,493
-295
-2% -$5.11K 0.01% 1100
2019
Q3
$214K Sell
13,788
-118
-0.8% -$1.94K ﹤0.01% 1116
2019
Q2
$239K Sell
13,906
-318
-2% -$5.13K 0.01% 1097
2019
Q1
$229K Buy
+14,224
New +$230K 0.01% 1085

Other funds holding HALO

Shell Asset Management's HALO Position: Q3 2025 in Review

Shell Asset Management reduced its Halozyme (HALO) stake by 58% in Q3 2025, selling an estimated $324K and leaving 3,570 shares worth $262K. The position accounts for 0.03% of the portfolio, ranked #430.

Shell Asset Management first reported a position in HALO in Q1 2019 and has held it in 26 quarters since. The position peaked at $634K in Q1 2025. 602 funds tracked by Wall St. Rank hold HALO as of Q3 2025.

  • Shell Asset Management held 3,570 shares of Halozyme worth $262K as of Q3 2025.
  • Shell Asset Management sold 4,872 Halozyme shares in Q3 2025, an estimated $324K.
  • Halozyme made up 0.03% of Shell Asset Management's portfolio in Q3 2025, its #430 holding.
  • Shell Asset Management first reported a position in Halozyme in Q1 2019 and has held it in 26 quarters since.
  • Shell Asset Management's Halozyme position peaked at $634K in Q1 2025.
  • 602 funds tracked by Wall St. Rank held Halozyme as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.